Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Technology

September 21, 2009 - Toshiba America Medical Systems Inc. introduced Low-Contrast Imaging (LCI) for Toshiba’s ...

Home September 21, 2009
Home
News

September 21, 2009 — Minnow Medical recently announced it will be presenting interim clinical data regarding a ...

Home September 21, 2009
Home
News

September 18, 2009 – Boston Scientific today said it completed patient enrollment in the workhorse portion of its ...

Home September 18, 2009
Home
News

September 18, 2009 – Following the recent CE mark certification of the vProtect Luminal Shield, the novel self ...

Home September 18, 2009
Home
Feature | Dave Fornell

When vessels are stretched and ripped via angioplasty balloon expansion, the exposed soft muscle tissue can lead ...

Home September 17, 2009
Home
Feature | Richard R. Rogoski

A trend that was fueled by cardiologists wanting to gain a larger share of reimbursement fees, while at the same ...

Home September 17, 2009
Home
Feature | Dave Fornell

Bare metal stents (BMS) were introduced in 1994 as an improvement over balloon angioplasty alone, which had a high ...

Home September 17, 2009
Home
News

September 18, 2009 ¬– Abbott has announced the company's schedule of key news announcements and events during the ...

Home September 17, 2009
Home
News

September 17, 2009 – NMT Medical Inc. said yesterday it will commence data analysis for its landmark STARFlex ...

Home September 17, 2009
Home
News

September 17, 2009 – Boston Scientific Corp. announced its schedule of the company's major events and press ...

Home September 17, 2009
Home
News

September 17, 2009 – Elixir Medical Corp. said today its stent systems using bioabsorbable polymers will be ...

Home September 17, 2009
Home
Feature | Dave Fornell

In August Daiichi Sankyo and Eli Lilly and Company launched U.S. sales of Effient (prasugrel), a new antiplatelet ...

Home September 17, 2009
Home
Feature | Dave Fornell

Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but ...

Home September 17, 2009
Home
tryton side branch stent, dedicated coronary side branch stent delivery balloon
Feature | Stents Bifurcation | Dave Fornell


Stenting of lesions at coronary vessel bifurcations is one of the most challenging percutaneous interventions ...

Home September 17, 2009
Home
Feature | Dave Fornell

Over the past year several new drug-eluting stents (DES) stents have been released and SYNTAX trial data proved ...

Home September 17, 2009
Home
Subscribe Now